69 related articles for article (PubMed ID: 38735008)
41. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.
Lucarelli G; Loizzo D; Franzin R; Battaglia S; Ferro M; Cantiello F; Castellano G; Bettocchi C; Ditonno P; Battaglia M
Expert Rev Mol Diagn; 2019 May; 19(5):397-407. PubMed ID: 30983433
[TBL] [Abstract][Full Text] [Related]
42. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.
Zhou Y; Zhou B; Pache L; Chang M; Khodabakhshi AH; Tanaseichuk O; Benner C; Chanda SK
Nat Commun; 2019 Apr; 10(1):1523. PubMed ID: 30944313
[TBL] [Abstract][Full Text] [Related]
43. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI; Plimack ER; Stus V; Gafanov R; Hawkins R; Nosov D; Pouliot F; Alekseev B; Soulières D; Melichar B; Vynnychenko I; Kryzhanivska A; Bondarenko I; Azevedo SJ; Borchiellini D; Szczylik C; Markus M; McDermott RS; Bedke J; Tartas S; Chang YH; Tamada S; Shou Q; Perini RF; Chen M; Atkins MB; Powles T;
N Engl J Med; 2019 Mar; 380(12):1116-1127. PubMed ID: 30779529
[TBL] [Abstract][Full Text] [Related]
44. Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment.
Tamma R; Rutigliano M; Lucarelli G; Annese T; Ruggieri S; Cascardi E; Napoli A; Battaglia M; Ribatti D
Urol Oncol; 2019 Jun; 37(6):355.e11-355.e19. PubMed ID: 30738745
[TBL] [Abstract][Full Text] [Related]
45. A CRISPR Screen Identifies LAPTM4A and TM9SF Proteins as Glycolipid-Regulating Factors.
Yamaji T; Sekizuka T; Tachida Y; Sakuma C; Morimoto K; Kuroda M; Hanada K
iScience; 2019 Jan; 11():409-424. PubMed ID: 30660999
[TBL] [Abstract][Full Text] [Related]
46. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.
Lucarelli G; Rutigliano M; Sallustio F; Ribatti D; Giglio A; Lepore Signorile M; Grossi V; Sanese P; Napoli A; Maiorano E; Bianchi C; Perego RA; Ferro M; Ranieri E; Serino G; Bell LN; Ditonno P; Simone C; Battaglia M
Aging (Albany NY); 2018 Dec; 10(12):3957-3985. PubMed ID: 30538212
[TBL] [Abstract][Full Text] [Related]
47. A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
Zhu B; Pan Y; Zheng X; Zhang Q; Wu Y; Luo J; Li Q; Lu E; Xu L; Jin G; Ren B
Gynecol Oncol; 2019 Feb; 152(2):396-407. PubMed ID: 30466806
[TBL] [Abstract][Full Text] [Related]
48. Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene.
Clark CR; Maile M; Blaney P; Hellweg SR; Strauss A; Durose W; Priya S; Habicht J; Burns MB; Blekhman R; Abrahante JE; Starr TK
Sci Rep; 2018 Oct; 8(1):15327. PubMed ID: 30333512
[TBL] [Abstract][Full Text] [Related]
49. The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.
Bianchi C; Meregalli C; Bombelli S; Di Stefano V; Salerno F; Torsello B; De Marco S; Bovo G; Cifola I; Mangano E; Battaglia C; Strada G; Lucarelli G; Weiss RH; Perego RA
Oncotarget; 2017 Dec; 8(69):113502-113515. PubMed ID: 29371925
[TBL] [Abstract][Full Text] [Related]
50. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Vasaikar SV; Straub P; Wang J; Zhang B
Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
[TBL] [Abstract][Full Text] [Related]
51. The human protein atlas: A spatial map of the human proteome.
Thul PJ; Lindskog C
Protein Sci; 2018 Jan; 27(1):233-244. PubMed ID: 28940711
[TBL] [Abstract][Full Text] [Related]
52. Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics.
Ragone R; Sallustio F; Piccinonna S; Rutigliano M; Vanessa G; Palazzo S; Lucarelli G; Ditonno P; Battaglia M; Fanizzi FP; Schena FP
Diseases; 2016 Jan; 4(1):. PubMed ID: 28933387
[TBL] [Abstract][Full Text] [Related]
53. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
[TBL] [Abstract][Full Text] [Related]
54. Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.
Ashikari D; Takayama K; Tanaka T; Suzuki Y; Obinata D; Fujimura T; Urano T; Takahashi S; Inoue S
Oncogene; 2017 Nov; 36(45):6272-6281. PubMed ID: 28692047
[TBL] [Abstract][Full Text] [Related]
55. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Zhang Q; Zheng X; Sun Q; Shi R; Wang J; Zhu B; Xu L; Zhang G; Ren B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1189-1196. PubMed ID: 28669730
[TBL] [Abstract][Full Text] [Related]
56. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Tang Z; Li C; Kang B; Gao G; Li C; Zhang Z
Nucleic Acids Res; 2017 Jul; 45(W1):W98-W102. PubMed ID: 28407145
[TBL] [Abstract][Full Text] [Related]
57. Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma.
Lucarelli G; Rutigliano M; Ferro M; Giglio A; Intini A; Triggiano F; Palazzo S; Gigante M; Castellano G; Ranieri E; Buonerba C; Terracciano D; Sanguedolce F; Napoli A; Maiorano E; Morelli F; Ditonno P; Battaglia M
Urol Oncol; 2017 Jul; 35(7):461.e15-461.e27. PubMed ID: 28359744
[TBL] [Abstract][Full Text] [Related]
58. Stress granule-associated protein G3BP2 regulates breast tumor initiation.
Gupta N; Badeaux M; Liu Y; Naxerova K; Sgroi D; Munn LL; Jain RK; Garkavtsev I
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1033-1038. PubMed ID: 28096337
[TBL] [Abstract][Full Text] [Related]
59. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E
J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186
[TBL] [Abstract][Full Text] [Related]
60. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.
Lucarelli G; Galleggiante V; Rutigliano M; Sanguedolce F; Cagiano S; Bufo P; Lastilla G; Maiorano E; Ribatti D; Giglio A; Serino G; Vavallo A; Bettocchi C; Selvaggi FP; Battaglia M; Ditonno P
Oncotarget; 2015 May; 6(15):13371-86. PubMed ID: 25945836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
